Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Owens & Minor (OMI) Share Price
News coverage about Owens & Minor (NYSE:OMI) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Owens & Minor earned a coverage optimism score of 0.11 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.1801548319749 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:
- Owens & Minor (OMI) Given “Sell” Rating at UBS (americanbankingnews.com)
- Owens & Minor (OMI) Rating Increased to Buy at Zacks Investment Research (americanbankingnews.com)
- Owens & Minor’s (OMI) Sell Rating Reiterated at UBS (americanbankingnews.com)
- Owens & Minor (OMI) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- Owens & Minor, Inc. (streetinsider.com)
OMI has been the subject of several recent research reports. Bank of America initiated coverage on shares of Owens & Minor in a research note on Tuesday, February 27th. They issued a “buy” rating and a $19.00 price target for the company. Zacks Investment Research raised shares of Owens & Minor from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. ValuEngine downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Barclays began coverage on shares of Owens & Minor in a research note on Thursday, March 8th. They set an “underweight” rating and a $16.00 price objective for the company. Finally, JPMorgan Chase lowered their price objective on shares of Owens & Minor from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Thursday, February 15th. Six equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $24.28.
Owens & Minor (NYSE:OMI) last issued its quarterly earnings data on Wednesday, February 14th. The company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.34 by $0.01. Owens & Minor had a net margin of 0.78% and a return on equity of 9.63%. The firm had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.34 billion. During the same period in the prior year, the firm posted $0.52 earnings per share. The company’s quarterly revenue was up .9% compared to the same quarter last year. research analysts forecast that Owens & Minor will post 2.05 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, March 30th. Investors of record on Thursday, March 15th were given a dividend of $0.26 per share. The ex-dividend date was Wednesday, March 14th. This represents a $1.04 annualized dividend and a dividend yield of 6.65%. This is a boost from Owens & Minor’s previous quarterly dividend of $0.26. Owens & Minor’s payout ratio is currently 64.60%.
About Owens & Minor
Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.